UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934



       Date of Report (date of earliest event reported): October 19, 2004


                           Commission File No. 0-11178
                                               -------


                           UTAH MEDICAL PRODUCTS, INC.
                           ---------------------------
             (Exact name of Registrant as specified in its charter)


                      UTAH                                87-0342734
       -----------------------------------           ------------------
         (State or other jurisdiction of              (I.R.S. Employer
         incorporation or organization)               Identification No.)


                               7043 South 300 West
                               Midvale, Utah 84047
                               -------------------
                     Address of principal executive offices


Registrant's telephone number:      (801) 566-1200
                                    --------------









--------------------------------------------------------------------------------
            ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
--------------------------------------------------------------------------------


Attached hereto as Exhibit 99.1 and incorporated by reference herein is
financial information for Utah Medical Products, Inc. for the quarter ended
September 30, 2004 and forward-looking statements relating to 2004 and beyond as
presented in a press release dated October 19, 2004. The information in this
report shall be deemed incorporated by reference into any registration statement
heretofore or hereafter filed under the Securities Act of 1933, as amended,
except to the extent that such information is superseded by information as of a
subsequent date that is included in or incorporated by reference into such
registration statement. The information in this report shall not be treated as
filed for purposes of the Securities Exchange Act of 1934, as amended.



--------------------------------------------------------------------------------
                                   SIGNATURES
--------------------------------------------------------------------------------

Pursuant to the requirements of the Securities Exchanges Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                                 UTAH MEDICAL PRODUCTS, INC.
                                                 ---------------------------
                                                 REGISTRANT


Date:         10/19/2004                         By:/s/ Kevin L. Cornwell
     ---------------------------------           ------------------------
                                                        Kevin L. Cornwell
                                                        CEO




--------------------------------------------------------------------------------

                                  EXHIBIT INDEX


Index
Number         Description
------         -----------
99.1           Financial information for Utah Medical Products, Inc. for the
               quarter ended September 30, 2004 and forward-looking statements
               relating to 2004 and beyond as presented in a press release dated
               October 19, 2004.